May 14, 2025

Public workspaceGCase assay - Resorufin β-D-glucopyranoside V.1

DOI
https://dx.doi.org/10.17504/protocols.io.n2bvj9kpplk5/v1
  • Enrico Bagnoli1,
  • Miratul Muqit2
  • 1MRC PPU;
  • 2University of Dundee
Enrico Bagnoli
Icon indicating open access to content
QR code linking to this content
DOI: https://dx.doi.org/10.17504/protocols.io.n2bvj9kpplk5/v1
Protocol Citation: Enrico Bagnoli, Miratul Muqit 2025. GCase assay - Resorufin β-D-glucopyranoside. protocols.io https://dx.doi.org/10.17504/protocols.io.n2bvj9kpplk5/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: February 27, 2025
Last Modified: May 14, 2025
Protocol Integer ID: 123539
Keywords: enzyme activity of lysosomal glucocerebrosidase, lysosomal glucocerebrosidase, protein lysate, glucopyranoside, enzyme activity, enzyme, gcase, assay, tissue lysate, variable expression of gba1
Funders Acknowledgements:
ASAP
Grant ID: ASAP-000463
Abstract
We present a method for assessing the enzyme activity of lysosomal glucocerebrosidase (GBA1, GCase) in protein lysates by monitoring the hydrolysis of the fluorescent substrate Resorufin β-D-glucopyranoside. The assay is conducted at low pH, where non-lysosomal glucocerebrosidase activity is expected to be minimal. This approach is supported by the complete loss of the fluorescent signal in GBA1 knockout (KO) cells. The assay is compatible with cell and tissue lysates, as well as organellar immunoprecipitations. Given the variable expression of GBA1 across different tissues and cell types, the amount of protein used in the assay can be adjusted accordingly.

Materials
Reagents
  • Resorufin β-D-glucopyranoside (Sigma, R4758)
  • Sodium taurocholate (Sigma, 86339)
  • Citric acid (Sigma, 251275)
  • Sodium phosphate dibasic (Sigma, S9763)
  • Dimethyl sulfoxide (DMSO, Sigma, D2650)
  • Ethylenediaminetetraacetic acid (EDTA,Sigma, E6511)
  • Bovine serum albumin (BSA, Sigma, A7906)

Buffers
  • 0.1M citric acid
  • 0.2M sodium phosphate
  • Citrate-phosphate buffer, pH 5.4
  • 0.5M EDTA, pH 8
  • Assay buffer: Citrate-phosphate buffer with 0.25% (w/v) sodium taurocholate, 1mM EDTA, 1% (w/v) BSA

Equipment and consumables
  • Fluoresce platereader with Ex = 571 nm and Em = 584 nm
  • FLUOTAC flat bottom black 96-well plate (Greiner, 655076)
Troubleshooting
Before start
The protocols provide instructions to perform GCase assay in protein lysates. Since the same quantity of protein is used, we recommend to quantify protein content before the assay is performed using any protein quantification method (e.g., BCA, Bradford, ...).
Buffers preparation
0.1 M citric acid:
Dissolve Amount19.2 g of citric acid in Amount1 L of dH2O
0.2 M sodium phospate
Dissolve Amount28.4 g of sodium phosphate dibasic in Amount1 L of dH2O
0.5 M EDTA
Dissolve Amount10.4 g of EDTA in Amount40 mL of dH2O. Bring the Ph8 and top up to Amount50 mL with dH2O

Prepare a fresh amount of assay buffer: Citrate-phosphate buffer with 0.25% (w/v) sodium taurocholate, 1mM EDTA. Approximately Amount200 µL are needed for each well of a 96 well plate.
For 20 ml of Assay Buffer:
  • Amount8.85 mL of 0.1 M citric acid
  • Amount11.15 mL of 0.2 M sodium phosphate
  • Amount50 mg of sodium taurocholate
  • Amount40 µL of 0.1 M EDTA
  • Check Ph5.4

Prepare 10% BSA in Assay buffer. A total of Amount20 µL per well are needed.
For 2ml:
  • WeightAmount200 mg of BSA
  • Dissolve in Amount2 mL of assay buffer
Resorufin β-D-glucopyranoside substrate:
Prepare a Concentration3.75 millimolar (mM) of Resorufin β-D-glucopyranoside in DMSO. Dilute this stock in assay buffer to obtain a working solution of Concentration187.5 micromolar (µM) (5x). A total of Amount40 µL of the 5x working solution is needed for each sample.
For a full 96 plate, so approx 4 ml:
  • Weight the substrate and dissolve in DMSO to obtain the Concentration3.75 millimolar (mM) solution. We normally weight around 1 mg.
  • Take Amount200 µL of the DMSO stock and dilute 1:20 in Amount3800 µL of assay buffer to obtain the 5x working solution Concentration187.5 micromolar (µM)

Note
Keep the diluted substrate in the dark.

Samples preparation
Defrost the protein lysates on ice and the lysis buffer used to generate the samples.

Note
Include GBA1 KO samples if possible.

In each well of a black 96 well-plate:
Pipette Amount15 µg of cell/tissue lysate. For Lyso-IP samples pipette Amount0.5 µg instead.

Note
We recommend running the samples in triplicates, or at least duplicates. Samples can be pipette directly into the wells of the 96-well plate, or a mastermix for each replicate can be done.

Protein amounts can be adjusted depending of the tissue and cell type used in the assay.

Top up volume to Amount20 µL with Lysis Buffer.

Note
If the samples are too diluted, the volume of lysis buffer to top up can be increased accordingly and the volume of assay buffer in the next step decreased of the same amount.

Add Amount120 µL of Assay Buffer.

Note
If more than Amount20 µL of samples have been used, reduce the amount of assay buffer added in this step accordingly.

Add Amount20 µL of 10% BSA.


Note
Include background control wells with:
Amount20 µL of lysis buffer
Amount120 µL of assay buffer
Amount20 µL of BSA


  • Add Amount40 µL of the Resorufin β-D-glucopyranoside substrate working solution aConcentration187.5 micromolar (µM) (5x).

Fluorescence Measurement and analysis
4h 2m
The fluorescence of each well was measured everyDuration00:02:00 s for Duration04:00:00 using a platereader with excitation: 571 nm and emission: 584 nm.

4h 2m
The raw RFU data were exported as a .csv file.

For each time point, average the background wells RFU.
Subtract the average background RFU for each time point from the samples RFU.



Average the technical replicates values (after background subtraction) for each time point.

Note
If GBA1 KO control is included it is possible to subtract also the signal from the GBA1 KO wells from the average of the samples technicals replicates.

Either plot the RFU over time for each sample or alternatively the end-point RFU as shown in the expected results section.
Calculate statistical significance using the appropriate test.
Expected result

GCase activity from 10 ug of lysates from A549 GBA1 KO after GBA1 rescue (blue) or rescue with emty vector (black), after background substraction.





Protocol references
Deen, Matthew C., Proceviat, Cameron, Shan, Xiaoyang et al. (2020) Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue Homogenates. ACS Chemical Biology. ISSN 1554-8937 https://doi.org/10.1021/acschembio.9b01044